BREAST ATYPICAL HYPERPLASIA
Clinical trials for BREAST ATYPICAL HYPERPLASIA explained in plain language.
Never miss a new study
Get alerted when new BREAST ATYPICAL HYPERPLASIA trials appear
Sign up with your email to follow new studies for BREAST ATYPICAL HYPERPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New study tests tamoxifen and Omega-3 combo to slash breast cancer risk in overweight women
Prevention Recruiting nowThis study looks at whether taking low-dose tamoxifen, alone or with high-dose omega-3 fatty acids, can lower breast cancer risk in overweight or obese postmenopausal women who are already at higher risk. About 66 women will take part. The goal is to see if adding omega-3s improv…
Matched conditions: BREAST ATYPICAL HYPERPLASIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated May 22, 2026 14:05 UTC
-
New hope for High-Risk women: can acolbifene outdo tamoxifen in breast cancer prevention?
Prevention Recruiting nowThis study tests two drugs, acolbifene and low-dose tamoxifen, to see which works better at preventing breast cancer in premenopausal women at high risk. Both drugs block estrogen from fueling breast cell growth. About 80 women will take one of the drugs for six months, and resea…
Matched conditions: BREAST ATYPICAL HYPERPLASIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated May 14, 2026 12:05 UTC